Related Experiment Video
Updated: Jul 1, 2026
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Effects of a Mobile Application for Patients With Type 2 Diabetes Initiating Insulin Therapy: Randomized Controlled
Nedime Hazal Döner1, Öznur Usta Yeşilbalkan2, Şevki Çetinkalp3
1Vocational School of Health Services, Elderly Care Program, Izmir University of Economics, İzmir, Türkiye.
International Journal of Nursing Practice
|June 30, 2026
Summary
A new mobile app significantly improved insulin knowledge, injection skills, and self-management for Type 2 diabetes patients starting insulin. The app also reduced negative attitudes towards insulin therapy, enhancing patient education and care.
Area of Science:
- Digital Health
- Diabetes Management
- Mobile Health Interventions
Background:
- Type 2 diabetes is a growing global health concern.
- Insulin therapy is crucial for managing advanced Type 2 diabetes.
- Effective patient education is vital for successful insulin initiation.
Purpose of the Study:
- To develop a mobile application for Type 2 diabetes patients initiating insulin therapy.
- To assess the app's impact on insulin knowledge, injection skills, self-management, and attitudes.
- To evaluate the app as an educational tool for diabetes self-management.
Main Methods:
- A randomized controlled trial with 88 participants.
- Intervention group (n=44) used a mobile app for insulin training.
- Control group (n=44) received standard care.
- Data collected at baseline, day 14, and day 28.
Main Results:
- The mobile app group showed significant increases in insulin knowledge, self-management, and injection skills.
- Negative attitudes towards insulin therapy decreased in the app group (p<0.05).
- No significant changes were observed in the control group (p>0.05).
Conclusions:
- The mobile application is effective for Type 2 diabetes self-management and promotes positive behavioral changes.
- The app serves as a valuable educational resource for individuals with Type 2 diabetes.
- Integration into nursing-led programs can enhance care continuity and support insulin initiation.
Related Concept Videos
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:16Insulin: Dosing Regimen and Adverse Effects
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood glucose levels...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...